Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study

MLA

Belén Gómez-Carrillo, et al. “Treatment of Alzheimer’s Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study.” Journal of Alzheimer’s Disease, vol. 33, Dec. 2012, pp. 205–15. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d117feef4e742b873afb5269a279dd92&authtype=sso&custid=ns315887.

APA

Belén Gómez-Carrillo, Teresa Leon, David Fleet, María V. Andrés, Pilar Redondo, Klaus C. Steinwachs, Miguel Medina, Hermann Josef Gertz, Teodoro Del Ser, & Joan A. Vericat. (2012). Treatment of Alzheimer’s Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study. Journal of Alzheimer’s Disease, 33, 205–215.

Chicago

Belén Gómez-Carrillo, Teresa Leon, David Fleet, María V. Andrés, Pilar Redondo, Klaus C. Steinwachs, Miguel Medina, Hermann Josef Gertz, Teodoro Del Ser, and Joan A. Vericat. 2012. “Treatment of Alzheimer’s Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study.” Journal of Alzheimer’s Disease 33 (December): 205–15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d117feef4e742b873afb5269a279dd92&authtype=sso&custid=ns315887.